Global Life Sciences Software Market is valued at ~$11 billion in 2020 and is anticipated to grow at a CAGR of ~11% to reach $18 billion by 2025
The market for life sciences software (such as eTMF, LIMS, computer-aided drug discovery, RWE, ERP, CRM, QMS, virtual trials, patient recruitment software, patient & outcomes data management, etc.) is driven by rising R&D spend and pipeline, expanding number and size of biotechs, Covid-accelerated decentralized trials, increasing cost efficiencies and shorter time to market.
The...
0 Комментарии
0 Поделились